Helix BioPharma

Helix BioPharma (#TSX: $HBP) is a clinical stage Immuno-Oncology #biotech. Focus on #Lung #Pancreatic #cancer with DOS47 platform technology

[Helix BioPharma @HelixBioPharma]

With FDA nod, Ridgeback's Ebanga joins Regeneron's Inmazeb in the Ebola-fighting arsenal! The FDA has approved a second Ebola treatment, Ebanga by Ridgeback Biotherapeutics! $REGN #Ebola #FDA
https://t.co/hOzbtZqK8P

[Helix BioPharma @HelixBioPharma]

As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth! Overall, Lilly's sales beat consensus estimates by about $170 million! $LLY #pharma #diabetes #Alzheimer
https://t.co/F0oWQxRv2Z

[Helix BioPharma @HelixBioPharma]

Interesting chart! Thanks! @bradloncar

3Q Keytruda sales $4.5B! All hail the King! $MRK $BMY #pharma

[Brad Loncar @bradloncar]

3Q Keytruda sales $4.5B. All hail the King.

[Helix BioPharma @HelixBioPharma]

Amplia Therapeutics secures renowned oncology drug development expert as clinical advisor! Dr Iglesias has more than 30 years’ experience in the pharmaceutical industry and has focused on creation of new oncology drugs! $ATX.AX $INNMF #PancreaticCancer
https://t.co/GbeMUGi5G4

[Helix BioPharma @HelixBioPharma]

Thanks for sharing! @ASCO @DrMMurphy @MadhuEluri #hemonc

[Madhu Eluri, MD @MadhuEluri]

Loving the @ASCO eLearning podcast and recommend other #hemonc trainees to check it out - current topics with experts, perfect for the 🚶🏻‍♀️or 🚙 to work!

[Helix BioPharma @HelixBioPharma]

BioNTech to start building mRNA vaccine manufacturing plant in Africa in mid-2022! The German biotech already ordered the initial assets and finalized planning for the facility! $BNTX $PFE #mRNA #COVID19Vaccine #Africa
https://t.co/jCrQEQ5EQM

[Helix BioPharma @HelixBioPharma]

Great news! Thanks for sharing! @MDAndersonNews Keep up the good work! @ChadTangMD @PavlosMsaouel #KidneyCancer #EndCancer
https://t.co/W29jI35XLm

[UT MD Anderson @UTMDAnderson]

A first-of-its kind Phase II clinical trial led by our Dr. Chad Tang found serial SBRT as a monotherapy is effective for patients with renal cell carcinoma: https://t.co/CQpBFGWQWW @ChadTangMD @PavlosMsaouel #KidneyCancer #EndCancer

[Helix BioPharma @HelixBioPharma]

Johnson & Johnson goes local to help Black, Hispanic patients left behind by health inequality! There is a concerted effort across the field to try to right or at least level the past wrongs! $JNJ #healthcare #inequality
https://t.co/0FERVeLW1u

[Helix BioPharma @HelixBioPharma]

Excellent! Thanks for sharing! @sanofi @SanofiUS @SanofiGenzyme $SNY #climatetargets #netzero #carbonneutral #SanofiResults #WeCanDoMore
https://t.co/6aXCeuPCH4

[Sanofi @sanofi]

Our CEO Paul Hudson reflects on our Q3 2021 performance and shares our accelerated #climatetargets to become #carbonneutral by 2030 and reach #netzero emissions by 2050.

Learn more: https://t.co/f9sMrd5ame

#SanofiResults #WeCanDoMore

[Helix BioPharma @HelixBioPharma]

Moderna Announces Swissmedic Authorizes Booster Dose of Moderna’s COVID-19 Vaccine! $MRNA #Covid19 #vaccine #Switzerland
https://t.co/7lD6VUT011

[Helix BioPharma @HelixBioPharma]

Excellent! Thanks for sharing! @BRAINCURES @BillGates @melindagates @gatesfoundation @Gavi @WHO @DavidCallahanIP

[Krzysztof Potempa @BRAINCURES]

@BillGates @melindagates' @gatesfoundation:
1⃣A founding partner of @Gavi
2⃣The largest private donor to the World Health Organization @WHO, second only to the US with its annual donation in 2018
3⃣@DavidCallahanIP expects the foundation's work to carry on
https://t.co/WKcx22MEG3

[Helix BioPharma @HelixBioPharma]

EMA starts rolling review of Merck's molnupiravir, continuing rapid regulatory response to COVID-19 antiviral data! The large pharma seeking approval on strength of data on 762 patients at high risk of disease progression! $MRK #Covid19 #antiviral #biotech
https://t.co/cjevvNNw7e

[Helix BioPharma @HelixBioPharma]

Excellent update! Thanks for sharing! @ASlavitt $MRK #pharma #COVID19

[Andy Slavitt 🇺🇦 @ASlavitt]

To expand access to a promising Covid-19 pill, Merck licensed it to a U.N.-backed group that will pick other companies to make it for low- and middle-income countries https://t.co/vZQFRxEee5

[Helix BioPharma @HelixBioPharma]

Juventas Cell Therapy closes a $63 million funding round as it eyes a big push for blood cancer hopeful! This comes amid a biotech boom in China, which is looking to boost its internal life science reputation! #biotech #celltherapy #cancer #China
https://t.co/t2dHxspQU5

[Helix BioPharma @HelixBioPharma]

Great care! Thanks for sharing! @MDAndersonNews @drmediget #BreastCancer #EndCancer
https://t.co/JHc2pnj2V2

[UT MD Anderson @UTMDAnderson]

When she was just six weeks pregnant, Gretchen Lee Herrera learned she had breast cancer.

How her MD Anderson care team put her at ease about her own health and the health of her unborn baby: https://t.co/mYbXI1R5bD @drmediget #BreastCancer #EndCancer

[Helix BioPharma @HelixBioPharma]

Novartis looks for silver lining in $2 billion canakinumab repurposing after 2nd lung cancer failure! Still, the data support further evaluation of the drug in lung cancer! $NVS $pharma #lungcancer #chemotherapy
https://t.co/0Z6KjAt8vV

[Helix BioPharma @HelixBioPharma]

Impressive! Thanks for sharing! @JohnCendpts

"A quiet cardio upstart makes some noise, getting $300M from Bain and diving deep into the clinic - with some real money for pipeline deals"

[John Carroll @JohnCendpts]

A quiet cardio upstart makes some noise, getting $300M from Bain and diving deep into the clinic -- with some real money for pipeline deals
https://t.co/fz7ycns5qO

[Helix BioPharma @HelixBioPharma]

AstraZeneca's Imfinzi strikes immunotherapy's first win in bile duct cancer, with Merck's Keytruda behind! Bile duct cancer marks drug's second positive gastrointestinal cancer readout in just a few days! $AZN $MRK #cancer #pharma #Immunotherapy
https://t.co/ADnqqEjrcV

[Helix BioPharma @HelixBioPharma]

Thanks for sharing! @GlopesMd @OncLive @MLJohnsonMD2 @SarahCannonDocs #OncLiveOnAir #lcsm #oncology
https://t.co/YhgRBVbkwm

[OncLive.com @OncLive]

In this episode of #OncLiveOnAir, @MLJohnsonMD2, of @SarahCannonDocs, discusses VS-6766 alone and in combination with defactinib, and expectations for the ongoing phase 2 RAMP 202 trial in KRAS-mutant NSCLC #lcsm #oncology https://t.co/6OJxvhQ89S

[Helix BioPharma @HelixBioPharma]

FDA Puts Ultimovac's Cancer Vaccine Support Therapy on Fast Track! The designation is based on data from two Phase I trials, which showed the drug to be safe, demonstrating early efficacy! $ULTI.OL #cancer #vaccine #FDA
https://t.co/oGUcMkt0LC

[Helix BioPharma @HelixBioPharma]

Excellent news! Thanks for sharing! @Merck $MRK #pharma #COVID19 #antiviral
https://t.co/nGWU1drZtr